Inicio › Cáncer de seno › Ohio
Ensayos clínicos de Cáncer de seno en Ohio
77 estudios sobre Cáncer de seno buscan participantes en Ohio.
Ciudades en Ohio
- Columbus39 estudios
- Cleveland33 estudios
- Cincinnati24 estudios
- Akron14 estudios
- Toledo7 estudios
- Dayton6 estudios
- Youngstown4 estudios
- Findlay4 estudios
- Newark3 estudios
- Zanesville3 estudios
- Mansfield3 estudios
- Wooster3 estudios
- Sandusky3 estudios
- Parma3 estudios
Texto oficial del estudio (inglés)
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- University Hospitals Seidman Cancer Center, Cleveland
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - , Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT05696626A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Cleveland Clinic Foundation, Cleveland
- The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc., Columbus
ReclutandoFase 1
Edades de 18 a 55 · Mujeres · Actualizado el 12 nov 2026 · NCT07310420S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Cleveland Clinic Akron General, Akron
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Aultman Health Foundation, Canton
- y 17 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03418961Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Research Facility, Cleveland
ReclutandoFase 1/2
Todas las edades · Todos los sexos · Actualizado el 12 nov 2026 · NCT06590857A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer
- Taylor Cancer Research Center, Maumee
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07905001A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027), Cincinnati
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06966700ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Gabrail Cancer Center, Canton
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07007559Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT06169371A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT03424005The Vanguard Study: Testing a New Way to Screen for Cancer
- Louis Stokes Cleveland VA Medical Center, Cleveland
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 6 nov 2026 · NCT06995898A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Cleveland Clinic, Cleveland
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07029399Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Cleveland Clinic, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Cleveland Clinic Akron General, Akron
- Aultman Hospital, Canton
- Gabrail Cancer Center, Canton
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07174336A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Hillcrest Hospital, Mayfield Heights
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06790693E-Mindfulness Approaches for Living After Breast Cancer
- Summa Health System - Akron Campus, Akron
- Summa Health System - Barberton Campus, Barberton
- Indu and Raj Soin Medical Center, Beavercreek
- y 19 más
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06748222Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Summa Health System - Barberton Campus, Barberton
- y 44 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT05579366Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Indu and Raj Soin Medical Center, Beavercreek
- Strecker Cancer Center-Belpre, Belpre
- Saint Elizabeth Boardman Hospital, Boardman
- y 11 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06418204A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- The Ohio State University (OSU) Wexner Medical Center, Columbus
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Cleveland Clinic - Oncology Department, Cleveland
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06760819Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Summa Health System - Akron Campus, Akron
- Cleveland Clinic Akron General, Akron
- Aultman Alliance Community Hospital, Alliance
- y 40 más
ReclutandoFase 3
Edades de 18 a 60 · Mujeres · Actualizado el 4 nov 2026 · NCT05879926A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07060807The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati Medical Center - West Chester Hospital, West Chester
ReclutandoFase 3
Edades de 60 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06377852Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- Cleveland Clinic Mercy Hospital, Canton
- University Hospitals Seidman Cancer Center, Cleveland
- Tri-County Hematology & Oncology Associates, Inc., Massillon
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT05974150A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Cleveland Clinic Taussig Cancer Institute, Cleveland
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06774963A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- UH Cleveland Medical Center, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07109726EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Aultman Timken Family Cancer Center, Canton
- Cleveland Clinic Main Campus, Cleveland
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT06401421A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Cleveland Clinic Mercy Hospital, Canton
- Cleveland Clinic Taussig Cancer Center, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT07100106Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- University of Cincinnati Medical Center, Cincinnati
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07287917The Cancer of the Pancreas Screening-5 CAPS5)Study
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT02000089Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
- Cleveland Clinic, Cleveland
- Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06875128BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- James Cancer Hospital and Solove Research Institute, Columbus
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT06120283Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Miami Valley Hospital South, Centerville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT05386108DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
- The Ohio State University, Columbus
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06749210Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06757634Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- The Ohio State University, Columbus
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT06784193The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- The Cleveland Clinic Taussig Cancer Center, Cleveland
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
- Taylor Cancer Research Center, Maumee
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06369285Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT05867251A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Cincinnati
- Research Site, Cincinnati
- Research Site, Cleveland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06103864De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.